Course Provider
Learning Objectives
Identify How FDA-approved gene & cell therapies are performing outside of controlled trial settings, including clinical efficacy, safety, access barriers, and health system readiness.
Describe the persistent challenges in scaling and sustaining gene and cell therapies, and identify emerging strategies, policies, or innovations that could enhance their integration into standard care.
Discuss a comprehensive overview of the current gene and cell therapy pipeline, from investigational stages to post-FDA approval, with emphasis on the transition into real-world clinical application.